Igniting Discovery: Contraline and the Future of Reversible Male Contraception

[madman]

In this episode of AUANews Inside Tract, Igniting Discovery, Kevin Eisenfrats, CEO of Contraline and 2025 Innovation Nexus Showcase winner, discusses the development of two novel male contraceptives, a daily hormonal gel (NEST) and a long-lasting, reversible implant (ADAM). He shares insights on clinical progress, regulatory strategy, and advice for innovators navigating the urology startup space through the AUA Innovation Nexus program.

Contraline

Contraline Product

Contraline News

 

[madman]

Thread 'Scientific Advances in Male Contraception'

Aug 27, 2022

Co-presented by Male Contraceptive Initiative and International Consortium on Male Contraception. Moderated by Heather Vahdat, Executive Director, MCI, and Dr. Regine Sitruk-Ware Population Council & ICMC. Panelists: Diana Blithe, Ph.D., Christina Wang, MD, Logan Nickels, Ph.D.

• madman
• concatreptive gel; transdermal; fertility; nes-t
• Replies: 16
• Forum: Testosterone and Men's Health Articles